Search for: "H. Lundbeck A/S et al"
Results 1 - 10
of 10
Sorted by Relevance
|
Sort by Date
18 Apr 2013, 3:37 am
Bigler et al. published in the May/June 1977 edition of the European Journal of Medicinal Chemistry). [read post]
17 Jan 2023, 9:38 am
Lundbeck A/S et al., 2022 ONSC 7160 (“Price”).[2] [read post]
18 Jan 2024, 9:16 am
Lundbeck A/S, et al. v. [read post]
15 Jun 2011, 4:56 am
Lundbeck A/S (IP Whiteboard) (Patentology) Focalin XR (Dexmethylphenidate) – US: Patent infringement complaint filed in response to Para IV certification: Celgene Corp. et al. v. [read post]
14 Jul 2010, 6:47 pm
Helm et al. [read post]
13 May 2010, 4:58 pm
Lundbeck A/S v. [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
16 Jan 2009, 7:00 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
18 Apr 2008, 2:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Ranbaxy and AstraZeneca reach agreement in Esomeprazole patent litigation: (SmartBrief), (IPBiz), (Spicy IP), (Profitability through Simplicity), (IP Law360), (Philip Brooks), (GenericsWeb), Cadbury loses Australian battle over exclusive use of colour purple for chocolate wrapping in its case against Darrell Lea: (Australian Trade Marks Law… [read post]
2 May 2008, 7:00 am
: (Patent Baristas), US: How to avoid a permanent injunction: the lessons of Amgen v Hoffman-LaRoche: (Patent Docs), US: Jarvik Heart’s PTE request based on PMA shell/module submission dates flatlines; ruling on initiation of PTE ‘review period’ mirrors FDA policy for ‘fast track’ products: (FDA Law Blog) Pharma & Biotech - Products Kytril (Granisetron) – Exclusivity ‘parking’ still… [read post]
